Medical News

RSS

EpiCept's first Ceplene commercial shipment to the EU triggers $2M milestone payment from Meda

EpiCept Corporation today announced that it has earned a $2 million milestone payment from Meda AB, for the first commercial shipment of Ceplene® (histamine dihydrochloride) to a major country in the European Union, as defined in the agreement.

4 May 2010

Opinions: Malaria bed net concerns; Catholic Church's humanitarian work; Abortion, global health; Foreign aid reform; Canada's G8 initiative

"To date, millions of dollars from international agencies, NGOs and USAID have been spent to get treated nets into the hands of impoverished, sub-Saharan Africans [to prevent malaria]. ... But, as even the staunchest advocate will admit, the treated nets were not designed with the cultural preferences of the rural African villager in mind," Sonia Shah, author of upcoming book about malaria, writes in a Los Angeles Times opinion piece.

4 May 2010

CalMHSA announces agreement with CDMH

The California Mental Health Services Authority (CalMHSA), a newly formed California joint powers authority (JPA) of counties focused on the efficient delivery of California mental health projects and programs, announced today it has entered into a contract with the California Department of Mental Health (CDMH) to provide program development, administrative oversight, and fiscal management services to county members and other program participants choosing to assign specifically named mental health funds to the joint powers authority.

4 May 2010

Researchers present positive results of Phase II clinical trial of eliglustat tartrate

Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.

4 May 2010

Broccoli component sulforaphane targets and kills breast cancer stem cells

A compound derived from broccoli could help prevent or treat breast cancer by targeting cancer stem cells -- the small number of cells that fuel a tumor's growth -- according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

4 May 2010

PTSD symptoms more common among childhood cancer survivors

Young adult survivors of childhood cancers are four times more likely to develop Post-Traumatic Stress Disorder (PTSD) than their control group siblings, a Childhood Cancer Survivors Study has found.

4 May 2010

Kidneys of healthy adults show signs of chronic mild injury that increase with age: Mayo Clinic

Mayo Clinic researchers have found that the kidneys of healthy adults show signs of chronic mild injury that increase with age. This damage is present even though the adults showed no clinical signs of kidney disease. The findings are reported in the current issue of the, Annals of Internal Medicine.

4 May 2010

Medtronic completes enrollment in first of two CURE-AF clinical trials

Medtronic, Inc., today announced completion of patient enrollment in the first of two studies in the company's CURE-AF (Concomitant Utilization of Radiofrequency Energy for Atrial Fibrillation) clinical trial.

4 May 2010

Statins may improve longevity of hip replacement surgery

The use of statins - drugs commonly prescribed to help lower cholesterol levels - may play an important role in decreasing complications among patients undergoing total hip replacement (THR), according to a study published in the May 2010 issue of the Journal of Bone and Joint Surgery (JBJS).

4 May 2010

Researchers convert established human iPS cells, ES cells to base state of greater pluripotency

Whitehead Institute researchers have converted established human induced pluripotent stem cells and human embryonic stem cells to a base state of greater pluripotency.

4 May 2010

NYBC urges community to donate blood in recognition of Mother's Day

New York Blood Center and its divisions serving the 20 million people of New York City, Long Island, the Hudson Valley, and New Jersey call upon the community to please donate blood in recognition of Mother's Day and families everywhere who are brought together by lives saved through the selfless gifts given by blood donors.

4 May 2010

Par Pharmaceutical signs exclusive licensing agreement with Glenmark to market ezetimibe in the U.S.

Par Pharmaceutical Companies, Inc. today announced that its generic division, Par Pharmaceutical, has entered into an exclusive licensing agreement with Glenmark Generics Limited and Glenmark Generics Inc., USA to market ezetimibe 10 mg tablets, the generic version of Merck & Co. Inc.'s Zetia, in the U.S. Zetia is a cholesterol modifying agent with annual U.S. sales of approximately $1.4 billion, according to IMS Health data.

4 May 2010

Intermedix Corporation acquires healthcare IT solution company, EMSystems

Intermedix Corporation, the leading provider of technology-based business services to emergency healthcare service providers, announced today the acquisition of EMSystems, LLC ("EMSystems"), a leading provider of web-based healthcare information technology solutions in the public health and emergency services markets.

4 May 2010

One-half of physicians do not recommend bariatric surgery for adolescents

Severely obese adolescents may desire or potentially benefit from bariatric surgery. However, half of primary care physicians say they would not recommend the procedure to a patient under the age of 18, according to research published in Obesity Surgery

4 May 2010

NIH awards Hutchinson Center $10.24M for research of breast cancer disparities in Hispanic women

The National Institutes of Health has awarded $10.24 million to Fred Hutchinson Cancer Research Center to lead a five-year study that aims to understand and prevent breast cancer disparities in Hispanic women.

4 May 2010

Young adult survivors of childhood cancer more likely to develop PTSD: Study

Young adult survivors of childhood cancers are four times more likely to develop Post-Traumatic Stress Disorder than their control group siblings, a Childhood Cancer Survivors Study has found.

4 May 2010

QIAGEN reports 20% revenue growth in first quarter 2010

QIAGEN N.V. today announced the results of operations for its quarter ended March 31, 2010. Net sales were at the high end of, and adjusted earnings per share for the first quarter 2010 exceeded the guidance provided by the Company on February 9, 2010.

From QIAGEN Manchester Limited 4 May 2010

TB Alliance, AstraZeneca sign research collaboration agreement to develop drugs against tuberculosis

The Global Alliance for TB Drug Development and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and clinical use of drugs against tuberculosis, including drug resistant strains of the disease.

4 May 2010

Stratatech to advance living human skin substitute tissue clinical trial with $3M funding round

Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.

4 May 2010

Guardian expands dental PPO network coverage by acquiring Preferred Dental Network

The Guardian Life Insurance Company of America, a leading provider of employee benefits, today announced that it will expand its dental PPO network coverage with the acquisition of Nevada-based Preferred Dental, LLC.

4 May 2010

Medical News

EpiCept's first Ceplene commercial shipment to the EU triggers $2M milestone payment from Meda

Opinions: Malaria bed net concerns; Catholic Church's humanitarian work; Abortion, global health; Foreign aid reform; Canada's G8 initiative

CalMHSA announces agreement with CDMH

Researchers present positive results of Phase II clinical trial of eliglustat tartrate

Broccoli component sulforaphane targets and kills breast cancer stem cells

PTSD symptoms more common among childhood cancer survivors

Kidneys of healthy adults show signs of chronic mild injury that increase with age: Mayo Clinic

Medtronic completes enrollment in first of two CURE-AF clinical trials

Statins may improve longevity of hip replacement surgery

Researchers convert established human iPS cells, ES cells to base state of greater pluripotency

NYBC urges community to donate blood in recognition of Mother's Day

Par Pharmaceutical signs exclusive licensing agreement with Glenmark to market ezetimibe in the U.S.

Intermedix Corporation acquires healthcare IT solution company, EMSystems

One-half of physicians do not recommend bariatric surgery for adolescents

NIH awards Hutchinson Center $10.24M for research of breast cancer disparities in Hispanic women

Young adult survivors of childhood cancer more likely to develop PTSD: Study

QIAGEN reports 20% revenue growth in first quarter 2010

TB Alliance, AstraZeneca sign research collaboration agreement to develop drugs against tuberculosis

Stratatech to advance living human skin substitute tissue clinical trial with $3M funding round

Guardian expands dental PPO network coverage by acquiring Preferred Dental Network

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News